Synergistic cortisol suppression by ketoconazole-osilodrostat combination therapy.

Amodru V, Brue T, Castinetti F.

Open source

DOI
10.1530/edm-21-0071
Published
2021-01-01
Container
Endocrinol Diabetes Metab Case Rep
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1530/edm-21-0071,
  title = {Synergistic cortisol suppression by ketoconazole-osilodrostat combination therapy.},
  author = {Amodru V and  Brue T and  Castinetti F.},
  year = {2021},
  journal = {Endocrinol Diabetes Metab Case Rep},
  doi = {10.1530/edm-21-0071},
  url = {https://doi.org/10.1530/edm-21-0071}
}

RIS

TY  - JOUR
TI  - Synergistic cortisol suppression by ketoconazole-osilodrostat combination therapy.
AU  - Amodru V
AU  -  Brue T
AU  -  Castinetti F.
PY  - 2021
JO  - Endocrinol Diabetes Metab Case Rep
DO  - 10.1530/edm-21-0071
UR  - https://doi.org/10.1530/edm-21-0071
ER  - 

APA

V, A., T, B., & F., C. (2021). Synergistic cortisol suppression by ketoconazole-osilodrostat combination therapy.. Endocrinol Diabetes Metab Case Rep. https://doi.org/10.1530/edm-21-0071

Source records